Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)Recruiting
NCT06968975N/AUpdated Jul 24, 2026
Sponsor: Sanofi
Polyneuropathy, Inflammatory Demyelinating, Chronic
United States
Tuberculosis Clinical Trials Consortium Study 35Completed
NCT03730181Phase 1, Phase 2Updated Jul 24, 2026
Sponsor: Centers for Disease Control and Prevention
Latent Tuberculosis
South Africa
Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male ParticipantsNot Yet Recruiting
NCT07726914Phase 1Updated Jul 24, 2026
Sponsor: Sanofi
Chronic Graft Versus Host Disease
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaActive Not Recruiting
NCT05346809Phase 2Updated Jul 23, 2026
Sponsor: Divaya Bhutani
Lymphoma · Multiple Myeloma · Non-Hodgkin Lymphoma · Relapsed Hodgkin's Disease, Adult
United States
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal CancerRecruiting
NCT07500298Phase 1Updated Jul 23, 2026
Sponsor: M.D. Anderson Cancer Center
Phase 1 · SAR445877 · FOlfox6 · Bevacizimab
United States
Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)Not Yet Recruiting
NCT07721649NAUpdated Jul 23, 2026
Sponsor: Stephan Baldus
Acute Coronary Syndrome · Heart Failure · Influenza, Human · Cardiovascular Diseases
Germany
Isatuximab in Patients With Monoclonal Gammopathy of Renal SignificanceActive Not Recruiting
NCT04614558Phase 2Updated Jul 23, 2026
Sponsor: Columbia University
Monoclonal Gammopathy
United States
A Study of SGN-CEACAM5C in Adults With Advanced Solid TumorsRecruiting
NCT06131840Phase 1Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisCompleted
NCT06130566Phase 3Updated Jul 22, 2026
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Canada +10 more
A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in TaiwanCompleted
NCT05684341NAUpdated Jul 21, 2026
Sponsor: Sanofi
Type 2 Diabetes Mellitus
Taiwan
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsActive Not Recruiting
NCT07646548Phase 1Updated Jul 21, 2026
Sponsor: Sanofi
Healthy Volunteers
United States
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive Not Recruiting
NCT06141473Phase 3Updated Jul 20, 2026
Sponsor: Sanofi
Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +36 more
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of AgeCompleted
NCT04520659Phase 1Updated Jul 20, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
RSV Infection
United States
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic AnemiaRecruiting
NCT07714512Phase 1, Phase 2Updated Jul 20, 2026
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Aplastic Anemia
China
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction CancerRecruiting
NCT07692204Phase 2Updated Jul 20, 2026
Sponsor: Sanofi
Gastric Cancer · Oesophageal Carcinoma
China
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)Completed
NCT04550962N/AUpdated Jul 20, 2026
Sponsor: Sanofi
Asthma
Argentina, Chile, Colombia, Israel, Kuwait +7 more
Universal Type 1 Diabetes Screening in PediatricsNot Yet Recruiting
NCT07612475N/AUpdated Jul 20, 2026
Sponsor: Northwestern University
Type 1 Diabetes (T1D)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseRecruiting
NCT06500702Phase 2Updated Jul 20, 2026
Sponsor: Sanofi
Focal Segmental Glomerulosclerosis · Glomerulonephritis Minimal Lesion
United States, Argentina, Australia, Brazil, Canada +17 more
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in ChinaNot Yet Recruiting
NCT07710872Phase 3Updated Jul 17, 2026
Sponsor: Sanofi
Meningococcal Infection · Healthy Volunteers
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)Active Not Recruiting
NCT04483739Phase 3Updated Jul 16, 2026
Sponsor: European Myeloma Network B.V.
Multiple Myeloma
Belgium, Czechia, Germany, Greece, Italy +3 more
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.Recruiting
NCT06892704N/AUpdated Jul 16, 2026
Sponsor: Northwestern University
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) · Smell Loss
United States
A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular DegenerationActive Not Recruiting
NCT06660667Phase 1, Phase 2Updated Jul 16, 2026
Sponsor: Sanofi
Neovascular Age-related Macular Degeneration
United States, United Kingdom
Isatuximab as Upfront Therapy for the Treatment of High Risk AL AmyloidosisActive Not Recruiting
NCT04754945Phase 1Updated Jul 14, 2026
Sponsor: Emory University
AL Amyloidosis
United States
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPEnrolling By Invitation
NCT06859099Phase 3Updated Jul 13, 2026
Sponsor: Sanofi
Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Brazil, Canada, Chile +16 more
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Active Not Recruiting
NCT05222906Phase 3Updated Jul 13, 2026
Sponsor: Sanofi
Gaucher's Disease Type III
United States, Argentina, Canada, China, France +6 more

Previous page Next page